{"product_id":"asn-onco-nephrology-core-curriculum-2023","title":"ASN Onco-Nephrology Core Curriculum 2023 (Videos + Slides)","description":"\u003cdiv class=\"specialOfferTitleWrapper\" id=\"MVStores_specialOfferTitleWrapper806\"\u003e\n\u003ch2\u003eASN Onco-Nephrology Core Curriculum 2023\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eThe recent proliferation in new cancer therapies has significantly improved survival and at the same time introduced brand new challenges for nephrologists. Some of these\u003c\/li\u003e\n\u003cli\u003einnovative therapies are directly nephrotoxic and others have introduced unique pathogenic mechanisms and patterns of renal injury.\u003c\/li\u003e\n\u003cli\u003eThis rapidly evolving landscape of malignancy and cancer treatment related kidney injury poses new challenges for the clinician in the evaluation and management of our\u003c\/li\u003e\n\u003cli\u003epatients. This updated ASN Onco-Nephrology curriculum addresses some of these novel clinical entities and provides information on innovations in laboratory and\u003c\/li\u003e\n\u003cli\u003ediagnostic techniques and on new management strategies that have recently developed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003ch4\u003e44 MP4 + 44 PPTX + 1 DOCX Files\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eOnco-Nephrology Core Curriculum 2023 - ASN (Videos + Slides) The recent proliferation in new cancer therapies has significantly improved survival and at the same time\u003c\/li\u003e\n\u003cli\u003eintroduced brand new challenges for nephrologists. Some of these innovative therapies are directly nephrotoxic and others have introduced unique pathogenic mechanisms\u003c\/li\u003e\n\u003cli\u003eand patterns of renal injury.\u003c\/li\u003e\n\u003cli\u003eThis rapidly evolving landscape of malignancy and cancer treatment related kidney injury poses new challenges for the clinician in the evaluation and management of our\u003c\/li\u003e\n\u003cli\u003epatients. This updated ASN Onco-Nephrology curriculum addresses some of these novel clinical entities and provides information on innovations in laboratory and\u003c\/li\u003e\n\u003cli\u003ediagnostic techniques and on new management strategies that have recently developed.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAcute Kidney Injury AKI in Cancer Patients.mp4Acute Kidney Injury AKI in Cancer Patients.pptx\u003c\/li\u003e\n\u003cli\u003eAcute Kidney Injury Effect of Cancer Treatments on Tubular Transport \u0026amp; Impact on GFR.mp4\u003c\/li\u003e\n\u003cli\u003eAcute Kidney Injury Effect of Cancer Treatments on Tubular Transport \u0026amp; Impact on GFR.pptx\u003c\/li\u003e\n\u003cli\u003eAcute Kidney Injury F18-fluoro-2-deoxy-D-glucose (F18-FDG) \u0026amp; The Kidney.mp4\u003c\/li\u003e\n\u003cli\u003eAcute Kidney Injury F18-fluoro-2-deoxy-D-glucose (F18-FDG) \u0026amp; The Kidney.pptx\u003c\/li\u003e\n\u003cli\u003ecute Kidney Injury Treatment Associated Acute Kidney Injury.mp4\u003c\/li\u003e\n\u003cli\u003eAcute Kidney Injury Treatment Associated Acute Kidney Injury.pptx\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney Genetic Screening for Hereditary Genitourinary Cancer Syndromes.mp4\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney Genetic Screening for Hereditary Genitourinary Cancer Syndromes.pptx\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney Kidney Cancer Overview.mp4\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney Kidney Cancer Overview.pptx\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney State of the Art Treatment of Multiple Myeloma.mp4\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney State of the Art Treatment of Multiple Myeloma.pptx\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney Surgical Management of Muscle Invasive Bladder Cancer Renal Function Implications.mp4\u003c\/li\u003e\n\u003cli\u003eCancers and the Kidney Surgical Management of Muscle Invasive Bladder Cancer Renal Function Implications.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Complication of Hematopoietic Cell Transplantation.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Complication of Hematopoietic Cell Transplantation.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Hematopoietic Cell Transplantation Basic Principles.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Hematopoietic Cell Transplantation Basic Principles.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies ICPI in Solid Organ Transplant.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies ICPI in Solid Organ Transplant.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies ICPI Managing Renal Adverse Effects.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies ICPI Managing Renal Adverse Effects.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Immune Checkpoint Inhibitor Associated Renal Pathology.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Immune Checkpoint Inhibitor Associated Renal Pathology.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Immune Checkpoint Inhibitors Immunobiology and Immune-related Adverse Events.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Immune Checkpoint Inhibitors Immunobiology and Immune-related Adverse Events.pptx\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Viral Nephritis in Hematopoietic Stem Cell Transplant Recipients.mp4\u003c\/li\u003e\n\u003cli\u003eCellular Therapeutics and Immunotherapies Viral Nephritis in Hematopoietic Stem Cell Transplant Recipients.pptx\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease Long-Term Kidney Outcomes Following Cisplatin, Methotrexate, Ifosfamide, Radiation Therapy and Thrombotic Microangiopathy.mp4\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease Long-Term Kidney Outcomes Following Cisplatin, Methotrexate, Ifosfamide, Radiation Therapy and Thrombotic Microangiopathy.pptx\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease Manifestations of Kidney Injury Graft vs Kidney Disease.mp4\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease Manifestations of Kidney Injury Graft vs Kidney Disease.pptx\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Cardio-oncology Targeted Cancer Therapy and Its Cardiovascular Effects.mp4\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Cardio-oncology Targeted Cancer Therapy and Its Cardiovascular Effects.pptx\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Management of Treatment Associated TMA.mp4\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Management of Treatment Associated TMA.pptx\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Pathogenesis of HTN with Targeted Therapies An Evidence-Based Discussion on Managing HTN from Targeted Therapies.mp4\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Pathogenesis of HTN with Targeted Therapies An Evidence-Based Discussion on Managing HTN from Targeted Therapies.pptx\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Thrombotic Microangiopathy.mp4\u003c\/li\u003e\n\u003cli\u003eComplications from Cancer Therapy Thrombotic Microangiopathy.pptx\u003c\/li\u003e\n\u003cli\u003eEthics Shared Decision-Making Before Dialysis Initiation or Termination in the Era of Novel Cancer Therapies.mp4\u003c\/li\u003e\n\u003cli\u003eEthics Shared Decision-Making Before Dialysis Initiation or Termination in the Era of Novel Cancer Therapies.pptx\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Dysnatremias in Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Dysnatremias in Cancer.pptx\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Fanconi Syndrome.mp4\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Fanconi Syndrome.pptx\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Magnesium Depletion in the Cancer Patient.mp4\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Magnesium Depletion in the Cancer Patient.pptx\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Malignancy-Associated Hypercalcemia.mp4\u003c\/li\u003e\n\u003cli\u003eFluid and Electrolyte Disorders Malignancy-Associated Hypercalcemia.pptx\u003cbr\u003eFluid Management in the Cancer Patient Cancer Screening in Patients with Chronic Kidney Disease and Kidney Transplant Recipients.mp4\u003c\/li\u003e\n\u003cli\u003eFluid Management in the Cancer Patient Cancer Screening in Patients with Chronic Kidney Disease and Kidney Transplant Recipients.pptx\u003c\/li\u003e\n\u003cli\u003eFluid Management in the Cancer Patient Edema in Patients with Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eFluid Management in the Cancer Patient Edema in Patients with Cancer.pptx\u003c\/li\u003e\n\u003cli\u003eManagement Management of Myelona Cast Nephropathy.mp4\u003c\/li\u003e\n\u003cli\u003eManagement Management of Myelona Cast Nephropathy.pptx\u003c\/li\u003e\n\u003cli\u003eManagement Monoclonal Protein Testing in the Management of MGRS Related Lesions.mp4\u003c\/li\u003e\n\u003cli\u003eManagement Monoclonal Protein Testing in the Management of MGRS Related Lesions.pptx\u003cbr\u003eManagement Treatment of Anemia in Patients with CKD and Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eManagement Treatment of Anemia in Patients with CKD and Cancer.pptx\u003c\/li\u003e\n\u003cli\u003eManagement Update on Amyloidosis.mp4\u003c\/li\u003e\n\u003cli\u003eManagement Update on Amyloidosis.pptx\u003c\/li\u003e\n\u003cli\u003eNephrotoxic Cancer Therapies Cisplatin – Nephrotoxicity Electrolyte Disorders.mp4\u003c\/li\u003e\n\u003cli\u003eNephrotoxic Cancer Therapies Cisplatin – Nephrotoxicity Electrolyte Disorders.pptx\u003c\/li\u003e\n\u003cli\u003eNephrotoxic Cancer Therapies Methotrexate-Associated Acute Kidney Injury.mp4\u003c\/li\u003e\n\u003cli\u003eNephrotoxic Cancer Therapies Methotrexate-Associated Acute Kidney Injury.pptx\u003c\/li\u003e\n\u003cli\u003eNephrotoxic Cancer Therapies Radiation Nephropathy.mp4\u003c\/li\u003e\n\u003cli\u003eNephrotoxic Cancer Therapies Radiation Nephropathy.pptx\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Amyloidosis.mp4\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Amyloidosis.pptx\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Case-Based Discussion of MGRS.mp4\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Case-Based Discussion of MGRS.pptx\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Kidney Pathology-Light Chain Cast Nephropathy and Other Myeloma-Related Kidney Disorders.mp4\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Kidney Pathology-Light Chain Cast Nephropathy and Other Myeloma-Related Kidney Disorders.pptx\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Pathology of MGRS.mp4\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Pathology of MGRS.pptx\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Renal Pathology Related to Cancer and Cancer Therapy.mp4\u003c\/li\u003e\n\u003cli\u003eRenal Pathology Renal Pathology Related to Cancer and Cancer Therapy.pptx\u003c\/li\u003e\n\u003cli\u003eRenal Transplant in the Cancer Patient Risks and Complications of Kidney Transplant in Patients with Hematologic Malignancies.mp4\u003c\/li\u003e\n\u003cli\u003eRenal Transplant in the Cancer Patient Risks and Complications of Kidney Transplant in Patients with Hematologic Malignancies.pptx\u003c\/li\u003e\n\u003cli\u003eSupplemental Answer Key-Blosser_Voigt.docx\u003c\/li\u003e\n\u003cli\u003eSupplemental Presentations Ethics Onco-Nephrology Clinical Ethics.mp4\u003c\/li\u003e\n\u003cli\u003eSupplemental Presentations Ethics Onco-Nephrology Clinical Ethics.pptx\u003c\/li\u003e\n\u003cli\u003eSupplemental Presentations Renal Transplant in the Cancer Patient Kidney Transplant after Solid Cancer \u0026amp; Risks and Complications of Kidney Transplant in Patients with\u003c\/li\u003e\n\u003cli\u003eSolid Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSupplemental Presentations Renal Transplant in the Cancer Patient Kidney Transplant after Solid Cancer \u0026amp; Risks and Complications of Kidney Transplant in Patients with\u003c\/li\u003e\n\u003cli\u003eSolid Cancer.pptx\u003c\/li\u003e\n\u003cli\u003eTumor Lysis Syndrome.mp4\u003cbr\u003eTumor Lysis Syndrome.pptx\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954368385122,"sku":"MED-AMB02037","price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ASN-Onco-Nephrology-Core-Curriculum-2023-Videos-Slides.jpg?v=1779374754","url":"https:\/\/meducourse.com\/products\/asn-onco-nephrology-core-curriculum-2023","provider":"Meducourse","version":"1.0","type":"link"}